Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Charting New Territory: Systematic Evaluation of the Drug Potential of <i>N</i>-Trifluoromethyl Amides, Ureas & Carbamates.

Journal of medicinal chemistry·2026
Same author

What Is in a Structure? Cell Permeability and Solubility of Series of Macrocycles and Linear Matched Pairs.

Journal of medicinal chemistry·2026
Same author

Correction: Regioselective synthesis of aza-saccharins <i>via</i> anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides.

Chemical science·2026
Same author

Regioselective synthesis of aza-saccharins <i>via</i> anionic [1,4] Fries-type rearrangement of aryl sulfonimidoyl fluorides.

Chemical science·2026
Same author

Exploring Secondary Structure Predictions for RNA-Targeted Drug Discovery: Power and Challenges.

Journal of chemical information and modeling·2026
Same author

Strategic Key Performance Indicators for AI in Lead Optimization.

ChemMedChem·2026
Same journal

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same journal

Red-Light-Triggered <i>In Vitro</i> and <i>In Vivo</i> Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

Journal of medicinal chemistry·2026
Same journal

Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

Journal of medicinal chemistry·2026
Same journal

HsClpP-Engaging Selective Mitochondrial Pan-PDK Degraders for Cancer Therapy.

Journal of medicinal chemistry·2026
Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
07:22

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)

Published on: January 12, 2024

Linker-Driven Sampling of PROTAC-Induced Ternary Complexes.

Hongtao Zhao1, Stefan Schiesser1, Christian Tyrchan1

  • 1Biopharma Chemistry, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg 43183, Sweden.

Journal of Medicinal Chemistry
|June 3, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces TERNIFY, a computational method for modeling ternary complexes crucial for Proteolysis-Targeting Chimeras (PROTACs) drug design. The software efficiently predicts complex structures, aiding in the development of novel therapeutics.

More Related Videos

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Jun 4, 2026

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
07:22

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)

Published on: January 12, 2024

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Area of Science:

  • Biochemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules inducing targeted protein degradation.
  • Formation of the ternary complex (PROTAC-E3 ligase-protein of interest) is critical for PROTAC efficacy.
  • Structural understanding of ternary complexes is vital for rational PROTAC design.

Purpose of the Study:

  • To develop and validate a computational approach for sampling PROTAC-induced ternary complexes.
  • To create an open-source software tool, TERNIFY, for streamlined ternary complex modeling.

Main Methods:

  • A computational method reducing search space to linker conformational degrees of freedom.
  • Validation using 40 cocrystal ternary complex structures.
  • Testing with unbound protein structures for WDR5-PROTAC-VHL complexes.

Main Results:

  • Achieved 97% and 50% retrospective success rates at Cα-RMSD thresholds of 10 and 4 Å, respectively.
  • Predicted ternary complexes were within 7 Å of experimental structures for WDR5-PROTAC-VHL complexes.
  • TERNIFY enables standalone ternary complex modeling without separate docking steps.

Conclusions:

  • The computational approach effectively samples PROTAC-induced ternary complexes.
  • TERNIFY provides an efficient, integrated workflow for ternary complex modeling.
  • This tool facilitates rational PROTAC design and accelerates therapeutic development.